U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Takeda, a global biopharmaceutical company with a manufacturing site in Stanton Springs, unveiled its new Biomedical Waste ...

Corundum Systems Biology (CSB), a leading investment company dedicated to advancing life-changing systems biology solutions for human health and well-being, today announced the appointment of two ...

A sampling of recent home goods from veteran craftspeople. By Arlene Hirst This article is part of our Design special section about the reverence for handmade objects. Today, in a world overrun ...

Hennessy funds manage $4.7 billion in assets and offers mutual funds and ETFs across different investment categories, including equity and sector-specific, and multi-asset strategies. It employs a ...

AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...

Takeda’s Adam Zaeske discusses how cross-sector ... by screening rare disease patients through application of AI and machine learning. Together the organisations are developing algorithms ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

The conference theme this year focused on collaboration, connection, and cultivation of the next generation of researchers.

The deal with the tech giant's Google Cloud unit revolves around its tensor processing units (TPUs), artificial intelligence-powered accelerators designed to run machine learning models and ...

With its extendable crane, the machine can reach heights of up to 12 ... common issue across the railway industry,” said Kazutaka Takeda, a track maintenance unit manager at JR East’s rail ...